“I established the task force in recognition that many of our health science faculty were individually already engaging in research, education and practice activities relevant to addressing the opioid epidemic,” said Carrie L. Byington, MD, dean of the Texas A&M College of Medicine, senior vice president of the Texas A&M University Health Science Center and vice chancellor for health services at The Texas A&M University System. “By working together, we can create an even greater impact in preventing and managing the devastating consequences faced by Texans and others around the country.”
The task force includes representatives from the five components of the center: dentistry, medicine, nursing, public health and pharmacy as well as the Coastal Bend Health Education Center. The task force will focus its efforts on research, education and practice issues associated with the opioid epidemic in Texas.
Two studies by task force members won funding for the first year of the 10-year, $100 million President’s Excellence Fund, T3: Texas A&M Triads for Transformation. These studies include the examination of the opioid epidemic’s impact on older adults and the development of a system for opiate withdrawal symptoms.
More articles on opioids:
Florida law puts 3-day limit on opioid prescriptions for acute pain
Trump: DOJ considering ‘major litigation’ against opioid companies
Medicaid essential to addressing opioid epidemic: 4 report insights
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.